Target intelligence / Profile preview

Receptor-type protein tyrosine phosphatase R (PTPRR)

Target
PTPRR
Molecular classification
Enzyme (specifically, protein tyrosine phosphatase), Receptor (receptor-type PTP), Signal transduction molecule
01

Overview

Receptor-type protein tyrosine phosphatase R (PTPRR) is a member of the classical protein tyrosine phosphatase family, functioning as an enzyme that removes phosphate groups from tyrosine residues on target proteins[1]. PTPRR is expressed in neuronal tissues and exists as multiple isoforms, including both receptor-type (transmembrane) and cytosolic forms[1]. It contains a kinase interaction motif (KIM), allowing it to interact with and inactivate mitogen-activated protein kinases (MAPKs), specifically ERK1/2/5 and p38, thus controlling their activity and preventing nuclear translocation[1]. PTPRR is involved in regulating neuronal development, endocytic trafficking, and fine-tuning signal transduction within the nervous system. Deficiency in PTPRR leads to defects in motor coordination without causing gross cerebellar morphological abnormalities, suggesting a critical role in signaling pathways that support precise neuronal functioning[1]. While protein tyrosine phosphatases, including PTPRR, have been implicated in diverse diseases such as neurodegeneration and cancer, PTPRR’s most well-described role centers on neuronal regulation and motor control[1][3].

Other names
PTPRRReceptor-type tyrosine-protein phosphatase RPTPBR7PTP-SLECPTPPCPTP1Ch-1PTPaseNC-PTPCOM1Cr1PTPase
02

Mechanism of action

For the protein tyrosine phosphatase family: inhibitors typically act by blocking enzymatic dephosphorylation activity and thereby modulating downstream signaling

03

Biological functions

Signal transductionRegulation of mitogen-activated protein kinase (MAPK) activityVesicular trafficking and endocytic transportRegulation of neuronal cell development and functionControl of motor coordination and balance
04

Disease associations

Neurodegenerative disease (specifically, motor coordination disorders, hereditary cerebellar ataxias)Potential roles in cancer and other conditions (due to aberrant PTP activity), but not firmly established for PTPRR specifically
05

Safety considerations

The main therapeutic challenge is selectivity—protein tyrosine phosphatases have highly conserved active sites, which increases off-target effects for candidate drugs in this enzyme familyRisk of broadly altered cell signaling, especially in nervous system function

Beyond the preview

Go deeper on Receptor-type protein tyrosine phosphatase R (PTPRR).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Receptor-type protein tyrosine phosphatase R (PTPRR).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call